Business Description
Compare
Compare
Traded in other countries / regions
BIOC.Egypt IPO Date
1985-10-23Description
GlaxoSmithKline is a pharmaceutical company. It is focused on developing new medicines in respiratory, HIV, oncology, and immune-inflation. The company is segmented into Commercial Operations and Total Research and development. It generates the majority of its revenue from the Commercial Operations segment.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 28.35 | |||||
9-Day RSI | 37.1 | |||||
14-Day RSI | 45.35 | |||||
3-1 Month Momentum % | 374.51 | |||||
6-1 Month Momentum % | 478.31 | |||||
12-1 Month Momentum % | 507.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.32 | |||||
Forward Dividend Yield % | 0.32 | |||||
5-Year Yield-on-Cost % | 0.31 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GlaxoSmithKline Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil E£) | 1,127.245 | ||
| EPS (TTM) (E£) | 3.23 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.76 | ||
| 3-Year Sortino Ratio | 6.19 | ||
| Volatility % | 244.62 | ||
| 14-Day RSI | 45.35 | ||
| 14-Day ATR (E£) | 51.023032 | ||
| 20-Day SMA (E£) | 443.0065 | ||
| 12-1 Month Momentum % | 507.62 | ||
| 52-Week Range (E£) | 55.1 - 563.99 | ||
| Shares Outstanding (Mil) | 83.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GlaxoSmithKline Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GlaxoSmithKline Stock Events
| Event | Date | Price (E£) | ||
|---|---|---|---|---|
| EGP 1.000000 Cash Dividend | 2026-01-12 | 62.93 (+0.90%) |
Show
Entries
GlaxoSmithKline Frequently Asked Questions
What is GlaxoSmithKline(CAI:BIOC)'s stock price today?
The current price of CAI:BIOC is E£333.50. The 52 week high of CAI:BIOC is E£563.99 and 52 week low is E£55.10.
When is next earnings date of GlaxoSmithKline(CAI:BIOC)?
The next earnings date of GlaxoSmithKline(CAI:BIOC) is .
Does GlaxoSmithKline(CAI:BIOC) pay dividends? If so, how much?
The Dividend Yield %  of GlaxoSmithKline(CAI:BIOC) is 0.32% (As of Today), Highest Dividend Payout Ratio of GlaxoSmithKline(CAI:BIOC) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of GlaxoSmithKline(CAI:BIOC) is 0.32%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on GlaxoSmithKline
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers